ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough esophageal cancer
Disease control OngoingThis study tests a new drug, cadonilimab, combined with chemotherapy and radiation for people with advanced esophageal cancer that cannot be removed by surgery. The goal is to see if this combination can better control the cancer and prevent it from coming back. About 46 adults a…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
Boosting Cancer-Killing cells: a new combo therapy trial
Disease control TerminatedThis early-phase trial tests whether giving healthy donor NK cells along with two drugs (vactosertib and IL-2) is safe and helps the cells survive longer in people with advanced colorectal, stomach/esophageal, or blood cancers. About 12 participants will receive the combination t…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Proton beam therapy may offer gentler radiation for esophageal cancer
Symptom relief OngoingThis study looks at whether proton beam therapy, a precise form of radiation, causes fewer severe side effects than standard radiation (IMRT) for people with esophageal cancer. About 22 patients with stage II or III esophageal cancer will receive proton therapy, and researchers w…
Matched conditions: ESOPHAGUS CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 06, 2026 16:00 UTC
-
New study aims to spot heart trouble early in cancer patients getting chest radiation
Knowledge-focused OngoingThis study looks for early signs of heart injury in people receiving radiation therapy for lung or esophageal cancer. Researchers use heart scans and blood tests to detect changes during or shortly after treatment. The goal is to identify patients at risk for heart problems and i…
Matched conditions: ESOPHAGUS CANCER
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:18 UTC